ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GA20221-25mg |
|
37642-65-2 |
(Hyp³)-Bradykinin
|
0 | C50H73N15O12 | |
GA20221-5mg |
|
37642-65-2 |
(Hyp³)-Bradykinin
|
0 | C50H73N15O12 | |
GA20220-1mg |
|
— |
(H-Lys-Ile-Leu-Asn-Asp-Leu-Ser-Ser-Asp-Ala-Pro-Gly-Val-Pro-Arg)₈-MAP
|
0 | C589H1002N175O185 | |
GA20219-25mg |
|
168916-68-5 |
(His³²,Leu³⁴)-Neuropeptide Y (32-36)
|
0 | C33H54N14O6 | |
GA20219-5mg |
|
168916-68-5 |
(His³²,Leu³⁴)-Neuropeptide Y (32-36)
|
0 | C33H54N14O6 | |
GA20218-5mg |
|
34367-54-9 |
(His(3-Me)²)-TRH
|
0 | C17H24N6O4 | |
GA20217-25mg |
|
34367-55-0 |
(His(1-Me)²)-TRH
|
0 | C17H24N6O4 | |
GA20217-5mg |
|
34367-55-0 |
(His(1-Me)²)-TRH
|
0 | C17H24N6O4 | |
GA20216-1g |
|
26798-52-7 |
(H-Gly-Cys-OH)₂
|
0 | C10H18N4O6S2 | |
GA20216-250mg |
|
26798-52-7 |
(H-Gly-Cys-OH)₂
|
0 | C10H18N4O6S2 | |
GA20215-1g |
|
144000-36-2 |
(H-D-Cys-OMe)₂ · 2 HCl
|
0 | C8H16N2O4S2 · 2 HCl | |
GA20215-250mg |
|
144000-36-2 |
(H-D-Cys-OMe)₂ · 2 HCl
|
0 | C8H16N2O4S2 · 2 HCl | |
GA20214-5g |
|
1259-69-4 |
(H-Cys-βNA)₂
|
0 | C26H26N4O2S2 | |
GA20214-1g |
|
1259-69-4 |
(H-Cys-βNA)₂
|
0 | C26H26N4O2S2 | |
GA20213-5g |
|
100900-22-9 |
(H-Cys-βNA)₂ · 2 HCl
|
0 | C26H26N4O2S2 · 2HCl | |
GA20213-1g |
|
100900-22-9 |
(H-Cys-βNA)₂ · 2 HCl
|
0 | C26H26N4O2S2 · 2HCl | |
GA20212-1g |
|
21141-84-4 |
(H-Cys-Val-OH)₂
|
0 | C16H30N4O6S2 | |
GA20212-250mg |
|
21141-84-4 |
(H-Cys-Val-OH)₂
|
0 | C16H30N4O6S2 | |
GA20211-1g |
|
7369-94-0 |
(H-Cys-Tyr-OH)₂
|
0 | C24H30N4O8S2 | |
GA20211-250mg |
|
7369-94-0 |
(H-Cys-Tyr-OH)₂
|
0 | C24H30N4O8S2 | |